
    
      Enrolled subjects will be transplanted with HuCNS-SC cells into the brain and will receive
      immunosuppression for nine months. The study observation period is for one year after
      transplant surgery. Thereafter, subjects will be enrolled in a long-term observational
      follow-up study for four years.
    
  